Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$232.09 - $256.88 $31.3 Million - $34.6 Million
-134,847 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$221.92 - $245.94 $3.85 Million - $4.27 Million
17,352 Added 14.77%
134,847 $33.8 Million
Q3 2020

Oct 29, 2020

BUY
$215.77 - $276.76 $920,906 - $1.18 Million
4,268 Added 3.77%
117,495 $27.3 Million
Q2 2020

Jul 27, 2020

BUY
$219.9 - $263.41 $3.15 Million - $3.77 Million
14,306 Added 14.46%
113,227 $27.2 Million
Q1 2020

Apr 14, 2020

SELL
$195.69 - $279.01 $1.51 Million - $2.15 Million
-7,696 Reduced 7.22%
98,921 $22.7 Million
Q4 2019

Jan 14, 2020

SELL
$236.45 - $266.82 $1.19 Million - $1.35 Million
-5,047 Reduced 4.52%
106,617 $29 Million
Q3 2019

Oct 10, 2019

BUY
$230.58 - $256.08 $24.9 Million - $27.7 Million
108,171 Added 3096.79%
111,664 $28.2 Million
Q2 2019

Jul 24, 2019

BUY
$217.4 - $246.08 $356,970 - $404,063
1,642 Added 88.71%
3,493 $878,000
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $21,635 - $26,057
105 Added 6.01%
1,851 $463,000
Q4 2018

Feb 12, 2019

SELL
$204.73 - $257.93 $9.9 Million - $12.5 Million
-48,362 Reduced 96.52%
1,746 $393,000
Q3 2018

Nov 09, 2018

BUY
$233.07 - $256.0 $11.2 Million - $12.4 Million
48,253 Added 2601.24%
50,108 $13.1 Million
Q1 2018

May 10, 2018

SELL
$205.46 - $240.27 $4.52 Million - $5.29 Million
-21,998 Reduced 92.22%
1,855 $402,000
Q4 2017

Feb 08, 2018

BUY
$189.0 - $222.64 $3.96 Million - $4.67 Million
20,973 Added 728.23%
23,853 $5.11 Million
Q2 2017

Aug 09, 2017

BUY
N/A
2,880
2,880 $562,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.